<p>Gain in body weight was not affected by LPS or EX-4 treatment in the normoglycemic (A) and hyperglycemic (B) mice. EX-4 treatment continuously decreased blood glucose (C) and increased insulin (D) in the hyperglycemic mice. Data are expressed as means ± S.E.M. (<i>n = </i>15–20 per group for body weight and blood glucose, <i>n = </i>6 per group for insulin). * <i>p</i><0.05; ** <i>p</i><0.01; *** <i>p</i><0.001.</p
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p><b>A</b>, Weight gain in control mice (white, n = 7) and mice fed a HFD (black, n = 5) and <b>B</...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
<p>Fasting blood glucose (FBG), random blood glucose (RBG), fasting serum insulin (FSI), and random ...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>A) Body weight B) serum insulin levels, and C) blood glucose during i.p. glucose tolerance test (...
<p>Glucose (A), glucose infusion rate (GIR 60–90 min) (B) and plasma insulin levels (C) during the c...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>A 90 min phloridzin (80 μg·kg<sup>−1</sup>·min<sup>−1</sup>)-glucose (115 mg·dL<sup>−1</sup>) cla...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>(A-D) Hyperinsulinemic-euglycemic clamps were performed on 12-week old ob/ob mice treated with GC...
<p>Average <b>(A)</b> body weight and <b>(B)</b> blood glucose values at 30-day intervals in the sha...
<p>(A–C) Male Bl6J mice were weaned to regular rodent chow (NC, 4.5% kcal fat diet) or high fat diet...
<p>(A) Body weight (<i>n</i> = 34, *<i>p</i><0.05). (B) Daily food intake (<i>n</i> = 14, *<i>p</i><...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p><b>A</b>, Weight gain in control mice (white, n = 7) and mice fed a HFD (black, n = 5) and <b>B</...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...
<p>Fasting blood glucose (FBG), random blood glucose (RBG), fasting serum insulin (FSI), and random ...
<p>A. Blood glucose levels of control and diabetic mice are shown as a function of time after the in...
<p>A: gastrocnemius weight of the mice during treatment in each group. B: quadriceps weight of the m...
<p>A) Body weight B) serum insulin levels, and C) blood glucose during i.p. glucose tolerance test (...
<p>Glucose (A), glucose infusion rate (GIR 60–90 min) (B) and plasma insulin levels (C) during the c...
<p>The body weight (A) and blood glucose levels (B) of C57BL/6 mice were measured once a week. Blood...
<p>A 90 min phloridzin (80 μg·kg<sup>−1</sup>·min<sup>−1</sup>)-glucose (115 mg·dL<sup>−1</sup>) cla...
<p>A: FPE decreased blood glucose in the experimental diabetic mice. B: FPE increased body weights i...
<p>(A-D) Hyperinsulinemic-euglycemic clamps were performed on 12-week old ob/ob mice treated with GC...
<p>Average <b>(A)</b> body weight and <b>(B)</b> blood glucose values at 30-day intervals in the sha...
<p>(A–C) Male Bl6J mice were weaned to regular rodent chow (NC, 4.5% kcal fat diet) or high fat diet...
<p>(A) Body weight (<i>n</i> = 34, *<i>p</i><0.05). (B) Daily food intake (<i>n</i> = 14, *<i>p</i><...
<p>(A,B) Fasting blood glucose (A) and insulin levels (B) in male non-progressing mice 30 weeks of a...
<p><b>A</b>, Weight gain in control mice (white, n = 7) and mice fed a HFD (black, n = 5) and <b>B</...
<p>Diabetic mice received or not MSCs (A). Diabetic mice received or not insulin prophylaxis and/or ...